TapewireFind a company

organization · Reporting owner

Einodmil LLC

Disclosed activity across 1 company

Tapewire entity
79990
SEC CIK
0002048829

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

OS Therapies Inc

Report date May 09, 2025 · Filed May 09, 2025

Jointly reported with Auerbach Shalom

Section 16 reporting ended · disclosed 2025-05-09. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 07, 2025 Filed May 9, 2025 21:30 UTC OS Therapies Inc OSTX · Entity 6950 SaleCommon Stock, par value $0.001 per share 82,000 $2.00 $163,918.00
Disclosure

SEC source: 0001641172-25-009543 · ownership.xml · nonDerivative · entry 1

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,664,199

F2 · price: The price reported in Column 4 is a weighted average price. These shares of Comm Stock were sold in multiple transactions at prices ranging from $1.69 to $2.22 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
April 10, 2025 Filed Apr 11, 2025 21:45 UTC OS Therapies Inc OSTX · Entity 6950 SaleCommon Stock, par value $0.001 per share 10,000 $1.39 $13,900.00
Disclosure

SEC source: 0001641172-25-003926 · ownership.xml · nonDerivative · entry 2

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,746,199

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
April 09, 2025 Filed Apr 11, 2025 21:45 UTC OS Therapies Inc OSTX · Entity 6950 SaleCommon Stock, par value $0.001 per share 50,012 $1.35 $67,666.24
Disclosure

SEC source: 0001641172-25-003926 · ownership.xml · nonDerivative · entry 1

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,756,199

F2 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $1.33 to $1.42 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
February 27, 2025 Filed Feb 28, 2025 16:05 UTC OS Therapies Inc OSTX · Entity 6950 OtherCommon Stock, par value $0.001 per share 225,000 $1.64 $369,000.00
Disclosure

SEC source: 0001493152-25-008695 · ownership.xml · nonDerivative · entry 1

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,806,211

F2 · kind: Forfeiture of shares of Common Stock that were held in escrow pursuant to a Transfer Agreement that Einodmil entered into on May 13, 2024. The shares of Common Stock were forfeited pursuant to the terms and conditions of the Transfer Agreement.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:00 UTC OS Therapies Inc OSTX · Entity 6950 SaleCommon Stock, par value $0.001 per share 100,000 $2.84 $284,300.00
Disclosure

SEC source: 0001493152-25-007236 · ownership.xml · nonDerivative · entry 1

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,431,211

F2 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $2.67 to $3.036 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:00 UTC OS Therapies Inc OSTX · Entity 6950 SaleCommon Stock, par value $0.001 per share 16,720 $6.74 $112,609.20
Disclosure

SEC source: 0001493152-25-002850 · ownership.xml · nonDerivative · entry 1

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,531,211

F2 · price: The price reported in Column 4 is a weighted average price. These shares of Comm Stock were sold in multiple transactions at prices ranging from $6.618 to $6.80 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $100,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 24

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 50,838 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $350,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 23

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 178,135 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $350,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $100,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 22

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 51,035 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $350,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 21

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 179,027 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $350,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $170,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 20

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 88,940 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $170,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $150,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 19

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 78,710 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $150,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $250,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 18

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 131,472 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $250,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $100,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 17

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 53,468 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $500,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 16

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 270,465 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $500,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $50,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 15

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 27,486 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $50,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $2.00 $1,150,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 14

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 633,980 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $1,150,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $1.31 $25,000.00
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · derivative · entry 13

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,371 shares

Expires 2024-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Mr. Auerbach in the principal amount of $25,000 at a conversion price of $1.31 per share.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 50,838 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 12

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,547,931

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 178,135 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 11

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,497,093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $350,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 51,035 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 10

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,318,958

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 179,027 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 9

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,267,923

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $350,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 88,940 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 8

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,088,896

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $170,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 78,710 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 7

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,999,956

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $150,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 131,472 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 6

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,921,246

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $250,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 53,468 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 5

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,789,774

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $100,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 270,465 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 4

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,736,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $500,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 27,486 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 3

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,465,841

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $50,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 633,980 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 2

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,438,355

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Einodmil in the principal amount of $1,150,000 at a conversion price of $2.00 per share.

F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Read SEC document
August 02, 2024 Filed Jan 14, 2025 20:26 UTC OS Therapies Inc OSTX · Entity 6950 ConversionCommon Stock, par value $0.001 per share 23,371 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-002247 · ownership.xml · nonDerivative · entry 1

Auerbach Shalom · CIK 0002048828 · 10% owner

Einodmil LLC · CIK 0002048829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,371

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The shares of Common Stock of the Issuer were issued upon the automatic conversion, which occurred upon the consummation of the Issuer's initial public offering on August 2, 2024, of a convertible promissory note held by Mr. Auerbach in the principal amount of $25,000 at a conversion price of $1.31 per share.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.